Amanda M. Pluntze

Jul 30, 2024 | drugdiscoveryonline.com | Jie Huang |Kimberly Shepard |Amanda M. Pluntze

Developing and ultimately obtaining approval of cell therapies for solid tumors requires an organized and scientifically rigorous approach. This article is a helpful road map of considerations. Simultaneous Spray Drying For Combination Dry Powder Inhaler FormulationsThree combination case studies are demonstrated, in which bevacizumab is paired with erlotinib, cisplatin, or paclitaxel in a dry powder inhaler formulation.

Jun 5, 2023 | outsourcedpharma.com | Srihari Rangarajan |Nathan Dormer |Kimberly Shepard |Amanda M. Pluntze |Louis Garguilo

By Outsourced Pharma Outsourced Pharma chief editor, Louis Garguilo, briefly interviews Dirk T. Lange, head of life science services, MilliporeSigma, at the 2023 CDMO Leadership Awards ceremony in Manhattan. Lange discusses MilliporeSigma’s awards, the "team sport" mentality, efforts behind the organization, and bringing clients' ideas to fruition.   By Mark Roache, Quality Executive Partners, Inc.